How does XLRI BM compare to IIM Ahmedabad for medical/MBBS backgrounds?
IIM Ahmedabad is the stronger placement outcome for MBBS backgrounds, but XLRI BM is not a consolation prize. The gap is real and measurable. If you can get into IIMA, take it without overthinking.
The Placement Gap Is Real
XLRI BM's median placement hovers around ₹30-32 LPA, while IIM Ahmedabad's median crosses ₹35 LPA with a mean salary above ₹35.22 LPA in recent batches. The top-end difference is sharper. IIMA sends students to McKinsey, BCG, and Boston Consulting Group in double-digit numbers each year.
XLRI BM gets a few spots at those firms, not a pipeline. Goldman Sachs and Morgan Stanley actively recruit from IIMA's finance cluster.
XLRI BM sees Kotak, Axis Capital, and mid-tier investment banks more consistently than bulge-bracket names.
For a medical background, this matters. You are likely targeting healthcare consulting, pharma strategy, or hospital operations.
McKinsey's healthcare practice and BCG's pharma vertical recruit almost exclusively from IIMs (particularly A, B, C) and ISB.
XLRI BM gets occasional looks from these teams but cannot guarantee access the way IIMA can.
Where XLRI BM Genuinely Holds Its Own
XLRI's BM programme has a focused healthcare management curriculum that IIMA's PGP does not replicate at the same depth. If you want to lead operations at Apollo, Manipal Health, or Narayana Health, XLRI BM's sectoral reputation in healthcare is respected.
HUL and ITC also recruit from XLRI BM for brand management roles, so the programme is not limited to healthcare.
The batch size at XLRI BM is smaller, which means individual attention during placement season is higher. Faculty interaction is genuine, not a numbers game.
If your goal is a hospital CEO track or running a diagnostics chain rather than consulting, XLRI BM is more than adequate and its alumni network in healthcare operations is underrated.
The Tier-1 Company Count
The honest reality: the number of firms sending more than one offer, and the number of roles per firm, drops at XLRI BM compared to IIMA. IIMA sees 30-40 companies in the first two days of placement.
XLRI BM's Day 1 list is shorter. For an MBBS graduate, this means fewer chances at the very top roles, not zero chances.
You can still land a Bain or Deloitte Consulting offer from XLRI BM, but you need to be among the top 10-15% of your batch, not the top 40-50%.
The Decision Framework
If you cleared CAT above 99 percentile and have a realistic shot at IIMA, do not settle for XLRI BM hoping the healthcare focus compensates. It does not, at least not in terms of brand value or starting CTC.
If your CAT score is in the 95-98 range and XLRI BM is your best realistic option, accept it. A strong XLRI BM graduate earning ₹28-32 LPA five years into healthcare consulting is doing far better than someone who chased IIMA and missed.
This path is hard for doctors. Your MBBS adds credibility in healthcare roles but you will be competing with engineers who studied finance for two years. Know that going in.
Pro Tip: Use your MBBS as a lever during XLRI BM's placement season by targeting pharma clients at Big 4 consulting firms (Deloitte, EY-Parthenon, KPMG) where clinical knowledge is a genuine differentiator over generalist MBAs.